MWM
TMO icon

Meridian Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Meridian Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Sell
815
-516
-39% -$248K 0.01% 597
2026
Q1 		$654K Buy
1,331
+81
+6% +$44K 0.02% 447
2025
Q4 		$724K Buy
1,250
+40
+3% +$22.6K 0.03% 410
2025
Q3 		$587K Buy
1,210
+67
+6% +$31.2K 0.02% 436
2025
Q2 		$464K Buy
1,143
+11
+1% +$4.6K 0.02% 462
2025
Q1 		$563K Sell
1,132
-43
-4% -$23.3K 0.03% 388
2024
Q4 		$611K Sell
1,175
-680
-37% -$374K 0.03% 375
2024
Q3 		$1.15M Buy
+1,855
New +$1.1M 0.06% 260
2024
Q1 		– Sell
-1,951
Closed -$1.04M – 515
2023
Q4 		$1.04M Sell
1,951
-196
-9% -$94.9K 0.07% 254
2023
Q3 		$1.09M Buy
2,147
+47
+2% +$25K 0.07% 222
2023
Q2 		$1.1M Buy
2,100
+134
+7% +$72.3K 0.09% 179
2023
Q1 		$1.13M Sell
1,966
-351
-15% -$198K 0.1% 187
2022
Q4 		$1.28M Buy
2,317
+635
+38% +$336K 0.12% 159
2022
Q3 		$853K Buy
1,682
+1,038
+161% +$581K 0.09% 207
2022
Q2 		$350K Buy
644
+151
+31% +$83.1K 0.03% 415
2022
Q1 		$291K Sell
493
-683
-58% -$392K 0.03% 319
2021
Q4 		$785K Buy
1,176
+463
+65% +$289K 0.08% 190
2021
Q3 		$407K Sell
713
-1,311
-65% -$720K 0.05% 252
2021
Q2 		$1.02M Sell
2,024
-696
-26% -$328K 0.13% 146
2021
Q1 		$1.24M Buy
2,720
+1,642
+152% +$784K 0.18% 108
2020
Q4 		$502K Buy
1,078
+237
+28% +$111K 0.08% 187
2020
Q3 		$371K Buy
841
+154
+22% +$63.6K 0.09% 161
2020
Q2 		$248K Buy
+687
New +$230K 0.08% 183

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Meridian Wealth Management's TMO Position: Q2 2026 in Review

Meridian Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 39% in Q2 2026, selling an estimated $248K and leaving 815 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #597.

Meridian Wealth Management first reported a position in TMO in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.28M in Q4 2022. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Meridian Wealth Management held 815 shares of Thermo Fisher Scientific worth $409K as of Q2 2026.
  • Meridian Wealth Management sold 516 Thermo Fisher Scientific shares in Q2 2026, an estimated $248K.
  • Thermo Fisher Scientific made up 0.01% of Meridian Wealth Management's portfolio in Q2 2026, its #597 holding.
  • Meridian Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 23 quarters since.
  • Meridian Wealth Management's Thermo Fisher Scientific position peaked at $1.28M in Q4 2022.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.